Published in
Taylor and Francis Group, OncoImmunology, 3(6), p. e1288331
DOI: 10.1080/2162402x.2017.1288331
Links
Tools
Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
Journal article published in 2017 by
Panagiotis Balermpas,
Daniel Martin,
Ulrike Wieland,
Margret Rave-Fränk,
Klaus Strebhardt 
,
Claus Rödel,
Emmanouil Fokas,
Franz Rödel
,
Claus Rödel,
Emmanouil Fokas,
Franz Rödel
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 